Quantum BioPharma is trading 5.11% up now at $3.40 after reporting second-quarter 2026 results and stronger liquidity on August 14, 2026.
- Reported approximately $9.5 million in combined cash, cash equivalents, and digital assets.
- Reduced operating expenses 53% year-over-year; said liquidity could fund planned operations through at least October 2027.
- FDA clearance for Lucid-MS Phase 2 was announced August 10.